<DOC>
	<DOCNO>NCT01756781</DOCNO>
	<brief_summary>This drug-drug interaction study compare pharmacokinetics 2 mg oral dose midazolam adult healthy woman non-childbearing potential administer alone administer along 8 daily 125 mg dos PD-0332991 . Volunteers randomize one two sequence . Volunteers sequence 1 receive midazolam alone treatment period 1 , follow multiple dose PD-0332991 midazolam treatment period 2 . Volunteers randomize sequence 2 receive multiple dose PD-0332991 midazolam treatment period 1 , follow washout period le 14 day receive midazolam alone treatment period 2 .</brief_summary>
	<brief_title>A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib ( PD-0332991 ) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women Non-Childbearing Potential .</brief_title>
	<detailed_description />
	<mesh_term>Palbociclib</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Healthy female nonchild bear potential age 18 65 year old . A Body Mass Index ( BMI ) 17.5 32.0 kg/m2 total body weight &gt; 50 kg ( 110 lb ) . A sign informed consent document . Any evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . A positive urine drug screen . Pregnant nursing female . Treatment investigational drug within 30 day 5 halflives first dose study medication .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>PD-0332991</keyword>
	<keyword>Midazolam</keyword>
	<keyword>Drug-Drug Interaction Study</keyword>
	<keyword>Healthy Adult Volunteer</keyword>
</DOC>